Frontiers in Cell and Developmental Biology, 2022 · DOI: 10.3389/fcell.2022.1065837 · Published: December 23, 2022
Retinoblastoma (RB) is a childhood eye cancer where early stages can be controlled but metastasis leads to high mortality. Non-coding RNAs (ncRNAs) affect cell processes like differentiation and proliferation, and their deregulation is linked to cancer, including RB. Some ncRNAs, such as miR-491-3p, act as tumor suppressors in RB, while others, like circ-E2F3, promote tumor growth. Understanding how ncRNAs regulate RB could offer new treatment options. This review discusses the roles of important ncRNAs in RB, their interactions with genes responsible for RB development, and their potential clinical uses for diagnosis, prognosis, or therapy.
ncRNAs can serve as prognostic or diagnostic biomarkers for retinoblastoma.
ncRNAs can be targeted in therapeutic regimens for RB.
Exosomal ncRNAs could be utilized for therapeutic purposes in RB treatment.